Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
BARRETT, MICHAEL P.
and
CROFT, SIMON L.
2014.
Emerging paradigms in anti-infective drug design.
Parasitology,
Vol. 141,
Issue. 1,
p.
1.
Leong, F. Joel
Li, Ruobing
Jain, Jay Prakash
Lefèvre, Gilbert
Magnusson, Baldur
Diagana, Thierry T.
and
Pertel, Peter
2014.
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers.
Antimicrobial Agents and Chemotherapy,
Vol. 58,
Issue. 10,
p.
6209.
Held, Jana
Jeyaraj, Sankarganesh
and
Kreidenweiss, Andrea
2015.
Antimalarial compounds in Phase II clinical development.
Expert Opinion on Investigational Drugs,
Vol. 24,
Issue. 3,
p.
363.
Kumar, Sushil
Kumari, Renu
and
Pandey, Richa
2015.
New insight-guided approaches to detect, cure, prevent and eliminate malaria.
Protoplasma,
Vol. 252,
Issue. 3,
p.
717.
Manjunatha, Ujjini H.
and
Smith, Paul W.
2015.
Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
Bioorganic & Medicinal Chemistry,
Vol. 23,
Issue. 16,
p.
5087.
Mischlinger, Johannes
Agnandji, Selidji T
and
Ramharter, Michael
2016.
Single dose treatment of malaria - current status and perspectives.
Expert Review of Anti-infective Therapy,
Vol. 14,
Issue. 7,
p.
669.
Turner, Helen
2016.
Spiroindolone Nitd609 is a Novel Antimalarial Drug that Targets the P-type Atpase PfATP4.
Future Medicinal Chemistry,
Vol. 8,
Issue. 2,
p.
227.
Phillips, Margaret A.
White, Karen L.
Kokkonda, Sreekanth
Deng, Xiaoyi
White, John
El Mazouni, Farah
Marsh, Kennan
Tomchick, Diana R.
Manjalanagara, Krishne
Rudra, Kakali Rani
Wirjanata, Grennady
Noviyanti, Rintis
Price, Ric N.
Marfurt, Jutta
Shackleford, David M.
Chiu, Francis C. K.
Campbell, Michael
Jimenez-Diaz, Maria Belen
Bazaga, Santiago Ferrer
Angulo-Barturen, Iñigo
Martinez, Maria Santos
Lafuente-Monasterio, Maria
Kaminsky, Werner
Silue, Kigbafori
Zeeman, Anne-Marie
Kocken, Clemens
Leroy, Didier
Blasco, Benjamin
Rossignol, Emilie
Rueckle, Thomas
Matthews, Dave
Burrows, Jeremy N.
Waterson, David
Palmer, Michael J.
Rathod, Pradipsinh K.
and
Charman, Susan A.
2016.
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria.
ACS Infectious Diseases,
Vol. 2,
Issue. 12,
p.
945.
Mishra, Mitali
Mishra, Vikash K.
Kashaw, Varsha
Iyer, Arun K.
and
Kashaw, Sushil Kumar
2017.
Comprehensive review on various strategies for antimalarial drug discovery.
European Journal of Medicinal Chemistry,
Vol. 125,
Issue. ,
p.
1300.
Phillips, M.A.
Rathod, P.K.
Rueckle, T.
Matthews, D.
Burrows, J.N.
and
Charman, S.A.
2017.
Comprehensive Medicinal Chemistry III.
p.
544.
De Souza Pereira, Caroline
Quadros, Helenita Costa
Aboagye, Samuel Yaw
Fontinha, Diana
D’Alessandro, Sarah
Byrne, Margaret Elizabeth
Gendrot, Mathieu
Fonta, Isabelle
Mosnier, Joel
Moreira, Diogo Rodrigo M.
Basilico, Nicoletta
Williams, David L.
Prudêncio, Miguel
Pradines, Bruno
and
Navarro, Maribel
2022.
A Hybrid of Amodiaquine and Primaquine Linked by Gold(I) Is a Multistage Antimalarial Agent Targeting Heme Detoxification and Thiol Redox Homeostasis.
Pharmaceutics,
Vol. 14,
Issue. 6,
p.
1251.
Efange, Noella M.
Lobe, Maloba M. M.
Yamthe, Lauve R. T.
Pekam, Jeannette N. M.
Tarkang, Protus A.
Ayong, Lawrence
and
Efange, Simon M. N.
2022.
Spirofused Tetrahydroisoquinoline-Oxindole Hybrids (Spiroquindolones) as Potential Multitarget Antimalarial Agents: Preliminary Hit Optimization and Efficacy Evaluation in Mice.
Antimicrobial Agents and Chemotherapy,
Vol. 66,
Issue. 12,
Umumararungu, Théoneste
Nkuranga, Jean Bosco
Habarurema, Gratien
Nyandwi, Jean Baptiste
Mukazayire, Marie Jeanne
Mukiza, Janvier
Muganga, Raymond
Hahirwa, Innocent
Mpenda, Matabishi
Katembezi, Alain Nyirimigabo
Olawode, Emmanuel Oladayo
Kayitare, Egide
and
Kayumba, Pierre Claver
2023.
Recent developments in antimalarial drug discovery.
Bioorganic & Medicinal Chemistry,
Vol. 88-89,
Issue. ,
p.
117339.
Amador, Luis A.
Rodríguez, Abimael D.
Carmona-Sarabia, Lesly
Colón-Lorenzo, Emilee E.
and
Serrano, Adelfa E.
2023.
Two Gracilioethers Containing a [2(5H)-Furanylidene]ethanoate Moiety and 9,10-Dihydroplakortone G: New Polyketides from the Caribbean Marine Sponge Plakortis halichondrioides.
Applied Sciences,
Vol. 14,
Issue. 1,
p.
281.
Amador, Luis A.
Colón-Lorenzo, Emilee E.
Rodríguez, Abimael D.
and
Serrano, Adelfa E.
2024.
Probing the Antiplasmodial Properties of Plakortinic Acids C and D: An Uncommon Pair of Marine Peroxide-Polyketides Isolated from a Two-Sponge Association of Plakortis symbiotica and Xetospongia deweerdtae Collected near Puerto Rico.
Life,
Vol. 14,
Issue. 6,
p.
684.